Table 2.
Cost-effectiveness analysis for 4 repeated measures vs. 1 measure
| Measurement error var. (% total var.) | Heritability (% total var.) | Ave ELOD ratio | Sample size savings | CR4,1 | CR4,2 |
|---|---|---|---|---|---|
| 11 (10%) | 0.20 (18%) | 1.17 | 0.15 | 16.31 | 31.20 |
| 0.60 (54%) | 1.23 | 0.19 | 12.04 | 26.75 | |
| 25 (20%) | 0.20 (16%) | 1.38 | 0.28 | 6.83 | 14.44 |
| 0.60 (48%) | 1.51 | 0.34 | 4.84 | 10.41 | |
| 67 (40%) | 0.20 (12%) | 2.01 | 0.50 | 1.97 | 4.55 |
| 0.60 (36%) | 2.28 | 0.56 | 1.34 | 3.33 | |
| 150 (60%) | 0.20 (8%) | 3.07 | 0.67 | 0.45 | 1.33 |
| 0.60 (24%) | 3.39 | 0.71 | 0.25 | 0.78 |
CRm1,m2 is defined in (5). CR4,2 is also listed here for comparison purpose. When Cs/Cp > CRm1,m2, taking m1 measures is better than taking m2 measures per subject. Heritability is defined as (σ2mg+ σ2pg)/(σ2mg+ σ2pg + σ2e) where σ2mg+ σ2pg + σ2e= 100 and the major gene effect s2mg is fixed to 20. Average of ELOD ratio is the average across three scenarios that give similar results: (1) a highly informative microsatellite marker with 20 alleles and 0 cM between the marker and the QTL. (2) Ten microsatellite markers each with 4 alleles and spaced 10 cM apart; the QTL placed in the middle of the markers. (3) Fifty SNPs spaced 2 cM apart; the QTL again placed in the middle of the SNPs.